Skip to content
777 Sourcing.

Capability

immunotherapy target identification

Suppliers
1
States & provinces
1
Countries
1

1 immunotherapy target identification supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

AGONOX INC

PORTLAND, OR

AgonOx is a cancer immunotherapy company developing TIL (tumor-infiltrating lymphocyte) therapies. It isolates and expands the CD39+CD103+ subset of a patient's tumor-infiltrating lymphocytes, the fraction that is tumor-reactive. Its lead program, AGX-148, is in Phase 1 in solid tumors, with additional cell therapy programs in IND-enabling studies. The company also identifies immunotherapy targets by studying human TIL isolated from tumor types, and designs recombinant proteins, antibodies, or small molecules to block and/or activate immune-specific path

antibody developmentin-vitro human immune assaysmouse tumor modelsrecombinant protein developmentsmall molecule developmentTIL isolation and expansion

Compiled from public sources

Related capabilities

Other processes offered by the shops that list immunotherapy target identification.

Browse all capabilities